SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026625
Filing Date
2018-05-09
Accepted
2018-05-09 16:07:55
Documents
38
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv492512_10q.htm 10-Q 261074
2 EXHIBIT 31.1 tv492512_ex31-1.htm EX-31.1 10322
3 EXHIBIT 31.2 tv492512_ex31-2.htm EX-31.2 10300
4 EXHIBIT 32.1 tv492512_ex32-1.htm EX-32.1 4244
5 EXHIBIT 32.2 tv492512_ex32-2.htm EX-32.2 4764
  Complete submission text file 0001144204-18-026625.txt   1665015

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20180331.xml EX-101.INS 223837
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20180331.xsd EX-101.SCH 22952
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20180331_cal.xml EX-101.CAL 30170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20180331_def.xml EX-101.DEF 126740
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20180331_lab.xml EX-101.LAB 166937
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20180331_pre.xml EX-101.PRE 143136
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 18818305
SIC: 2836 Biological Products, (No Diagnostic Substances)